Comment: Has the state finally got a good deal on medicine prices?
New deal not brilliant, but better than predecessor, writes Susan Mitchell
Yesterday, Minister for Health Simon Harris announced that significant savings would be made by the State under a new pricing and supply agreement.
This deal is between the Irish Pharmaceutical Healthcare Association (IPHA), which represents most major research-based pharma companies, and the State.
The headline savings certainly look impressive. The Department of Health estimates those savings would amount to €600m over four years from members of IPHA. IPHA had a more positive spin ...
